RECQL4 is an important DDR marker that promotes both NHEJ and HR.[33] The HR pathway can cause HR defects that cannot repair dsDNA breaks, making tumor cells highly sensitive to platinum drugs and poly‐ADP‐ribose polymerase (PARP) inhibitors. The gene discussed is RECQL4; the disease is neoplasm.